BACKGROUND: Hypoadiponectinemia predicts the development of diabetes and hypertension, both being potent atherosclerotic risk factors. Whether adiponectin predicts the progression of early atherosclerosis remains unclear. In this 5-year prospective study, we examined the relationship between serum adiponectin and carotid intima media thickness (CIMT), a marker of subclinical atherosclerosis. METHODS: A total of 265 subjects from the population-based Hong Kong Cardiovascular Risk Factor Prevalence Study, with no known cardiovascular disease, underwent CIMT measurement at baseline and at 5 years. RESULTS: In all, 129 men and 136 women, aged 54.6±12.3 years, were studied. Median CIMT at baseline was 0.63 mm (interquartile range 0.52-0.73 mm) and increased to 0.67 mm (0.56-0.78 mm) after 5 years (P<0.001). CIMT increment correlated with baseline adiponectin, age, and smoking (all P<0.05) and baseline CIMT (P<0.001), but not with sex, fasting glucose, lipid profiles, hypertension, or diabetes. In multiple linear regression analysis, baseline serum adiponectin level was an independent predictor of CIMT increment β (standardized beta)=-0.17, P=0.015], after adjusting for age, smoking, baseline CIMT, hypertension, body mass index, fasting glucose, low-density lipoprotein cholesterol, and triglycerides. CONCLUSION: Hypoadiponectinemia predicted CIMT progression, independent of known predictive factors such as age, smoking, hyperlipidemia, and hypertension.
BACKGROUND:Hypoadiponectinemia predicts the development of diabetes and hypertension, both being potent atherosclerotic risk factors. Whether adiponectin predicts the progression of early atherosclerosis remains unclear. In this 5-year prospective study, we examined the relationship between serum adiponectin and carotid intima media thickness (CIMT), a marker of subclinical atherosclerosis. METHODS: A total of 265 subjects from the population-based Hong Kong Cardiovascular Risk Factor Prevalence Study, with no known cardiovascular disease, underwent CIMT measurement at baseline and at 5 years. RESULTS: In all, 129 men and 136 women, aged 54.6±12.3 years, were studied. Median CIMT at baseline was 0.63 mm (interquartile range 0.52-0.73 mm) and increased to 0.67 mm (0.56-0.78 mm) after 5 years (P<0.001). CIMT increment correlated with baseline adiponectin, age, and smoking (all P<0.05) and baseline CIMT (P<0.001), but not with sex, fasting glucose, lipid profiles, hypertension, or diabetes. In multiple linear regression analysis, baseline serum adiponectin level was an independent predictor of CIMT increment β (standardized beta)=-0.17, P=0.015], after adjusting for age, smoking, baseline CIMT, hypertension, body mass index, fasting glucose, low-density lipoprotein cholesterol, and triglycerides. CONCLUSION:Hypoadiponectinemia predicted CIMT progression, independent of known predictive factors such as age, smoking, hyperlipidemia, and hypertension.
Authors: Aimin Xu; Kok Weng Chan; Ruby L C Hoo; Yu Wang; Kathryn C B Tan; Jialiang Zhang; Baoying Chen; Michael C Lam; Cynthia Tse; Garth J S Cooper; Karen S L Lam Journal: J Biol Chem Date: 2005-03-09 Impact factor: 5.157
Authors: A W K Tso; P C Sham; N M S Wat; A Xu; B M Y Cheung; R Rong; C H Y Fong; J Y Xu; K K Y Cheng; E D Janus; K S L Lam Journal: Diabetologia Date: 2006-06-21 Impact factor: 10.122
Authors: Peter M Nilsson; Gunnar Engström; Bo Hedblad; Jan Frystyk; Margaretha M Persson; Göran Berglund; Allan Flyvbjerg Journal: Arterioscler Thromb Vasc Biol Date: 2006-10-12 Impact factor: 8.311
Authors: Janet Lo; Sara E Dolan; Jenna R Kanter; Linda C Hemphill; Jean M Connelly; Robert S Lees; Steven K Grinspoon Journal: J Clin Endocrinol Metab Date: 2006-03-07 Impact factor: 5.958
Authors: Angela Sciacqua; Maria Adelaide Marini; Marta Letizia Hribal; Francesco Perticone; Giorgio Sesti Journal: PLoS One Date: 2013-01-09 Impact factor: 3.240
Authors: Ellen E Lee; Dorothy D Sears; Jinyuan Liu; Hua Jin; Xin M Tu; Lisa T Eyler; Dilip V Jeste Journal: J Psychiatr Res Date: 2019-06-18 Impact factor: 4.791
Authors: Monica Zocchi; Matteo Della Porta; Federico Lombardoni; Roberta Scrimieri; Gian Vincenzo Zuccotti; Jeanette A Maier; Roberta Cazzola Journal: Biomedicines Date: 2022-06-07
Authors: Pilar Cobeta; Roberto Pariente; Alvaro Osorio; Marta Marchan; Marta Cuadrado-Ayuso; David Pestaña; Julio Galindo; José I Botella-Carretero Journal: Biomedicines Date: 2022-08-17